18 January 2017
News and Views
Links and Services
March's issue of the Alimentary Pharmacology & Therapeutics reviews whether interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection.
Interferon lambda 3 (IFN-λ3) polymorphisms are the strongest genetic predictor of outcome of
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors